You searched for Economics of Innovation - Page 2 of 18 - OHE

We found for

CBO Report

Insight
September 2021

Does the New CBO Report Change Anything?

blog-4-quote-1-002-v2

Insight
September 2021

Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking

blog-3-graph-1_smaller

Insight
September 2021

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation

Blog-2-quote-2-small

Insight
September 2021

The CBO Doesn’t Understand Investors

test-image-5

Insight
September 2021

H.R. 3 is the Wrong Policy for the Wrong Problem

Insight
September 2021

OHE is Launching a New Series to Explore the Latest Attempts to Reduce the Cost of US Healthcare

Insight
July 2021

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Key-Learnings-small

Insight
April 2021

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Insight
March 2021

Time to Tackle the Challenges around Combination Therapies for Cancer

Insight
March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Read more

Payment Models for Multi-Indication Therapies

Read more

© Photology1971/Shutterstock

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Read more

The Lower Drug Costs Now Act and Pharmaceutical Innovation

Read more

Insight
January 2021

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments

01
02
03
04
05
06
00